Analgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain

Not Applicable

Withdrawn

• Conditions: Neck Pain; Head Pain
• Interventions: Device: Ultrasound-guided Dry-Needling Therapy

• Registration Number: NCT03869710
• Lead Sponsor: San Salvatore Hospital of L'Aquila

Brief Summary

The analgesic effects of ultrasound-guided dry-needling therapy will be evaluated in the management of head and neck pain.

Detailed Description

The analgesic effects of ultrasound-guided dry-needling therapy will be evaluated in the management of head and neck pain by myofascial active and latent trigger point.

The myofascial pain control will be assessed for the superficial and deep posterolateral muscle complex of neck. The analgesic request, Range Of Motion (ROM), Motion Related Pain (MRP) and the quality of life, will be also assessed.

Study Timeline

• Study Start: 2019-03-08
• Study First Submitted: 2019-03-08
• Study First Submitted QC: 2019-03-08
• Study First Posted: 2019-03-11
• Primary Completion: 2023-12-25
• Study Completion: 2023-12-25
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-29
• Last Update Posted: 2024-12-03

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

• Chronic neck pain
• Chronic head pain

Exclusion Criteria

• previous surgery of neck and head
• Body Mass Index > 39,99
• politrauma patients
• pregnancy
• neck and head infections

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Dry-Needling	Ultrasound-guided Dry-Needling Therapy	Ultrasound-Guided Dry-Needling Therapy focused on the active and latent myofascial trigger points.

Primary Outcome Measures

Name	Time	Method
Trigger Point	The first hour of the treatment	The number of the elicited myofascial trigger points assessed during dry-needling treatment

Secondary Outcome Measures

Name	Time	Method
Analgesic request	3 months trom treatment	The analgesic request will be assessed in mg of equianalgesic morphine
Karnofsky Performance Status	3 months from treatment	The quality of life assessed by Karnofsky Performance Status (a 0-100 steps scale, from 0 \[Dead\] to 100 \[Normal no complaints; no evidence of disease\]).
Range Of Motion (ROM)	3 months after treatment	The alpha angle expressed in degrees and assessed during
Motion Related Pain	3 months after treatment	Pain assessed by Numeric Rating Scale (a 10-steps scale, from 0 \[no pain\] to 10 \[worse pain\]), during flexion, extension and rotation of neck and head
Perception	3 months after treatment	Pain assessed by Numeric Rating Scale (a 10-steps scale, from 0 \[no pain\] to 10 \[worse pain\])

Trial Locations

Locations (1)

San Salvatore Academic Hospital; 🇮🇹 Coppito, L'Aquila, Italy